A disruptive glucose biosensor for Type 2 Diabetic patients
The MELLIsense project has received an seal of excellence from the European Commission in 2020
Radically change the care of Type 2 Diabetic patients with one insulin injection per day
Type 2 Diabetes: poor blood glucose levels
Serious deterioration of their health
380 million people
MELLIsense is the only integrated solution comprising a continuous glucose biosensor and smartphone application specifically designed for Type 2 Diabetic patients. Patients can do small but valuable changes in their daily lifestyle, making step by step progress…
…for the same price as finger-prick solutions
MELLIsense is a comprehensive solution which includes :
A continuous glucose biosensor (CGM)
An activity tracker
A software application for smartphone that embeds:
Diabetes specialist expertise
State of the art therapeutic education for Type 2 Diabetic patients.
The MELLIsense wearable glucose biosensor offers a seamless sensing solution which frees patients from the burden of daily finger-prick glucose measurements.
MELLIsense combines proprietary algorithms which embed the clinical expertise of diabetes specialists to provide a personalised analysis and recommendations to patients.